Volume | 6 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Catalyst Pharmaceuticals Inc | CPRX | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
16.08 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
2 | 6 | - | 11.09 - 18.22 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
04:36:00 | 1 | $ 16.44 | USD |
Catalyst Pharmaceuticals Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
1.9B | 117.86M | - | 398.2M | 71.41M | 0.61 | 26.54 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Catalyst Pharmaceuticals News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CPRX Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 16.24 | 17.02 | 15.75 | 16.20 | 1,698,954 | -0.16 | -0.99% |
1 Month | 14.00 | 17.495 | 13.49 | 15.76 | 1,580,099 | 2.08 | 14.86% |
3 Months | 16.66 | 17.495 | 13.1161 | 15.09 | 1,526,801 | -0.58 | -3.48% |
6 Months | 12.65 | 17.495 | 11.55 | 14.24 | 1,363,069 | 3.43 | 27.11% |
1 Year | 16.07 | 18.22 | 11.09 | 14.17 | 1,526,003 | 0.01 | 0.06% |
3 Years | 4.19 | 22.11 | 4.15 | 12.04 | 1,625,015 | 11.89 | 283.77% |
5 Years | 3.25 | 22.11 | 2.235 | 8.46 | 1,798,374 | 12.83 | 394.77% |
Catalyst Pharmaceuticals Description
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing innovative therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome. |